SCHEMBL17599545

SCHEMBL17599545

Cc1cc(C)c(C)c(S(=O)(=O)Nc2cc(C(CC(=O)OC(C)(C)C)c3ccccc3)cc3ccccc23)c1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.47
▸ HPGD P15428 5/20 0.47
▸ MEN1 O00255 5/20 0.47
▸ KMT2A Q03164 5/20 0.47
▸ HSD17B10 Q99714 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ CRHBP P24387 1/20 0.47
▸ CRHR2 Q13324 1/20 0.47
▸ KEAP1 Q14145 6/20 0.38
▸ NFE2L2 Q16236 3/20 0.38
▸ GAA P10253 2/20 0.36
▸ TSHR P16473 1/20 0.36
▸ LMNA P02545 3/20 0.35
▸ HKDC1 Q2TB90 2/20 0.35
▸ MAPT P10636 1/20 0.35
▸ G6PD P11413 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ BLM P54132 1/20 0.35
▸ MCL1 Q07820 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17599526 0.87 ALDH1A1 (0.53) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL17599546 0.84 MEN1 (0.45) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL17614109 0.81 BRD4 (0.33) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL17599554 0.75 KMT2A (0.45) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL17599555 0.75 KMT2A (0.45) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL17599543 0.75 KDM4E (0.43) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL17599536 0.74 KDM4E (0.47) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL17599472 0.72 ALDH1A1 (0.41) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL17599552 0.70 KDM4E (0.47) ALDH1A1HPGDMEN1KMT2AHSD17B10
SCHEMBL17599525 0.70 KMT2A (0.51) ALDH1A1HPGDMEN1KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
EP-2998292-A1 Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders SANOFI (FR) 2016-03-23 — — EP disclosed
Send feedback